Menu Close

Trending

AbbVie and Cugene partner to tackle autoimmune diseases
2nd Annual mRNA-Based Therapeutics Summit
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Do pharmaceutical businesses need to rethink what their graduate schemes offer?
AstraZeneca extends oncology partnership with Proteros

Tunnah

 

Articles/ Audio/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Healthcare/ Market Access/ Patients/ Webinars/ Webinars On demand

Available on-demand: COPD, connecting real world needs to patient centric solutions

, , , , , , , , , , , , , 0 Comment

  COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and

X
Available on-demand: COPD, connecting real world needs to patient centric solutions
https://pharmaphorum.com/debates-insight-patients/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/
 

Articles/ Audio/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Market Access/ Patients/ Pharma Market Access/ Webinars/ Webinars On demand

Available on-demand: The Price is Right? – Delivering UK access for niche patient populations

, , , , , , , , , , , , , , , , 0 Comment

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what

X
Available on-demand: The Price is Right? – Delivering UK access for niche patient populations
https://pharmaphorum.com/debates-insight-market-access/live-webinar-the-price-is-right-uk-niche-market-access/

Login

CONTINUE TO SITE >
X
Close in 10 seconds